A Randomised Trial of Conformal versus Conventional Radiotherapy in Pelvic Neoplasms

ISRCTN ISRCTN17264730
DOI https://doi.org/10.1186/ISRCTN17264730
ClinicalTrials.gov number NCT00867347
Secondary identifying numbers ICR/PELVIC
Submission date
19/08/2002
Registration date
19/08/2002
Last edited
03/01/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr - -
Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer: Bladder (advanced), Bladder (superficial), Multiple Sites, Prostate, Rectum
Intervention1. Group A: Conventional radiotherapy using a three field technique employing rectangular fields. Suggested dosage, 64 Gy in 2 Gy fractions five times a week
2. Group B: Conformal radiotherapy using a three field technique employing fields shaped with customised blocks drawn according to the beam's-eye view of the target volume. Suggested dosage, 64 Gy in 2 Gy fractions five times a week.
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2001
Completion date31/12/2001

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Carcinoma of the pelvic region (eg prostate, bladder, rectum, etc)
2. Patients scheduled to undergo pelvic radiotherapy by a CT planned technique with less than four fields provided a satisfactory localisation on the simulator can be achieved
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2001
Date of final enrolment31/12/2001

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom

Sponsor information

The Institute of Cancer Research (UK)
Government

123 Old Brompton Road
London
SW7 3RP
United Kingdom

Website http://www.icr.ac.uk
ROR logo "ROR" https://ror.org/043jzw605

Funders

Funder type

Research organisation

Institute of Cancer Research (UK)
Government organisation / National government
Alternative name(s)
Institute of Cancer Research - CIHR, CIHR Institute of Cancer Research, L'Institut du cancer, Institut du cancer, ICR - CIHR, ICR, IC
Location
Canada

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/1997 Yes No